XML 22 R7.htm IDEA: XBRL DOCUMENT v3.24.0.1
Consolidated Statements of Redeemable Convertible Preferred Stock and Stockholders’ Equity (Deficit) - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-In Capital
Accumulated Other Comprehensive Income (Loss)
Accumulated Deficit
Redeemable convertible preferred stock, beginning balance (in shares) at Dec. 31, 2020 85,391,338        
Redeemable convertible preferred stock, beginning balance at Dec. 31, 2020 $ 274,104        
Increase (Decrease) in Temporary Equity [Roll Forward]          
Exercise of Series A-1 redeemable convertible preferred stock warrants (in shares) 12,595        
Exercise of Series A-1 redeemable convertible preferred stock warrants $ 163        
Conversion of redeemable convertible preferred stock to common stock upon initial public offering (in shares) (85,403,933)        
Conversion of redeemable convertible preferred stock to common stock upon initial public offering $ (274,267)        
Redeemable convertible preferred stock, ending balance (in shares) at Dec. 31, 2021 0        
Redeemable convertible preferred stock, ending balance at Dec. 31, 2021 $ 0        
Beginning balance (in shares) at Dec. 31, 2020   35,627,503      
Beginning balance at Dec. 31, 2020 (260,685) $ 0 $ 117,818 $ 0 $ (378,503)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Conversion of redeemable convertible preferred stock to common stock upon initial public offering (in shares)   85,403,933      
Conversion of redeemable convertible preferred stock to common stock upon initial public offering 274,267 $ 1 274,266    
Issuance of common stock in connection with initial public offering, net of issuance costs and underwriting discount (in shares)   15,150,000      
Issuance of common stock in connection with initial public offering, net of issuance costs and underwriting discount 408,416   408,416    
Stock-based compensation 36,701   36,701    
Exercise of stock options (in shares)   2,921,957      
Exercise of stock options 11,028   11,028    
Vesting of restricted stock units (in shares)   61,300      
Cumulative translation adjustment (1)     (1)  
Net loss attributable to common stockholders (80,026)       (80,026)
Ending balance (in shares) at Dec. 31, 2021   139,164,693      
Ending balance at Dec. 31, 2021 $ 389,700 $ 1 848,229 (1) (458,529)
Redeemable convertible preferred stock, ending balance (in shares) at Dec. 31, 2022 0        
Redeemable convertible preferred stock, ending balance at Dec. 31, 2022 $ 0        
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Stock-based compensation 87,152   87,152    
Exercise of stock options (in shares)   1,569,999      
Exercise of stock options 7,004   7,004    
Vesting of restricted stock units (in shares)   3,408,672      
Vesting of restricted stock units 307 $ 0 307    
Issuances of common stock under employee stock purchase plan (in shares)   870,422      
Reclassification of stock appreciation rights 62   62    
Issuance of common stock under employee stock purchase plan 9,192   9,192    
Other comprehensive income (loss) (232)     (232)  
Cumulative translation adjustment (20)        
Net loss attributable to common stockholders (153,875)       (153,875)
Ending balance (in shares) at Dec. 31, 2022   145,013,786      
Ending balance at Dec. 31, 2022 $ 339,310 $ 1 951,946 (233) (612,404)
Redeemable convertible preferred stock, ending balance (in shares) at Dec. 31, 2023 0        
Redeemable convertible preferred stock, ending balance at Dec. 31, 2023 $ 0        
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Stock-based compensation 104,772   104,772    
Exercise of stock options (in shares)   5,477,153      
Exercise of stock options 17,996   17,996    
Vesting of restricted stock units (in shares)   6,134,641      
Vesting of restricted stock units 512 $ 1 511    
Issuances of common stock under employee stock purchase plan (in shares)   1,029,344      
Issuance of common stock under employee stock purchase plan 8,043   8,043    
Shares withheld related to net share settlement of equity awards (in shares)   (488,564)      
Shares withheld related to net share settlement of equity awards (6,760)   (6,760)    
Other comprehensive income (loss) 313     313  
Cumulative translation adjustment 25        
Net loss attributable to common stockholders (107,294)       (107,294)
Ending balance (in shares) at Dec. 31, 2023   157,166,360      
Ending balance at Dec. 31, 2023 $ 356,892 $ 2 $ 1,076,508 $ 80 $ (719,698)